bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Up 6.6% in November

bioMérieux S.A. (OTCMKTS:BMXMF) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 139,000 shares, an increase of 6.6% from the November 15th total of 130,400 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 1,390.0 days.

Analysts Set New Price Targets

Separately, UBS Group raised shares of bioMérieux to a “strong-buy” rating in a research report on Thursday, August 22nd.

bioMérieux Price Performance

OTCMKTS:BMXMF opened at $107.03 on Tuesday. bioMérieux has a 1-year low of $93.50 and a 1-year high of $122.52. The firm has a 50-day moving average of $108.32 and a two-hundred day moving average of $107.61.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.